Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents
This is a proof-of-principle study, that uses freshly resected human solid tumor specimens to assess the performance of topically applied fluorescent imaging agents for the detection of tumor tissue and close / tumor-positive resection margins ex vivo. Surgery will be performed in conformity with hospital protocol. The study will not interfere with the standard clinical care.
- EligibilityCriteria: Inclusion Criteria:  Patients with a biopsy-proven solid tumor, scheduled for surgery at the Erasmus Medical Center. Signed and dated informed consent obtained before any study-related procedure is performed.  Exclusion Criteria:  Terminated surgical procedure. No fresh specimen available. Participation in a clinical trial for which the patient receives another fluorophore perioperatively. - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult